Patents by Inventor Brian J. Mossop

Brian J. Mossop has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11890472
    Abstract: Devices, systems and methods are provided for targeted treatment of a variety of conditions, particularly conditions that are associated with or influenced by the nervous system, such as pain. Targeted treatment of such conditions is provided with minimal deleterious side effects, such as undesired motor responses or undesired stimulation of unaffected body regions. This is achieved by directly neuromodulating a target anatomy associated with the condition while minimizing or excluding undesired neuromodulation of other anatomies.
    Type: Grant
    Filed: November 30, 2020
    Date of Patent: February 6, 2024
    Assignee: TC1 LLC
    Inventors: Eyad Kishawi, Mir A. Imran, Brian J. Mossop, Jeffery M. Kramer, Richard W. O'Connor
  • Publication number: 20210093866
    Abstract: Devices, systems and methods are provided for targeted treatment of a variety of conditions, particularly conditions that are associated with or influenced by the nervous system, such as pain. Targeted treatment of such conditions is provided with minimal deleterious side effects, such as undesired motor responses or undesired stimulation of unaffected body regions. This is achieved by directly neuromodulating a target anatomy associated with the condition while minimizing or excluding undesired neuromodulation of other anatomies.
    Type: Application
    Filed: November 30, 2020
    Publication date: April 1, 2021
    Inventors: Eyad KISHAWI, Mir A. IMRAN, Brian J. MOSSOP, Jeffery M. KRAMER, Richard W. O'CONNOR
  • Publication number: 20190054300
    Abstract: Devices, systems and methods are provided for targeted treatment of a variety of conditions, particularly conditions that are associated with or influenced by the nervous system, such as pain. Targeted treatment of such conditions is provided with minimal deleterious side effects, such as undesired motor responses or undesired stimulation of unaffected body regions. This is achieved by directly neuromodulating a target anatomy associated with the condition while minimizing or excluding undesired neuromodulation of other anatomies.
    Type: Application
    Filed: October 23, 2018
    Publication date: February 21, 2019
    Inventors: Eyad KISHAWI, Mir A. IMRAN, Brian J. MOSSOP, Jeffery M. KRAMER, Richard W. O'CONNOR
  • Patent number: 10105541
    Abstract: Devices, systems and methods are provided for targeted treatment of a variety of conditions, particularly conditions that are associated with or influenced by the nervous system, such as pain. Targeted treatment of such conditions is provided with minimal deleterious side effects, such as undesired motor responses or undesired stimulation of unaffected body regions. This is achieved by directly neuromodulating a target anatomy associated with the condition while minimizing or excluding undesired neuromodulation of other anatomies.
    Type: Grant
    Filed: August 28, 2017
    Date of Patent: October 23, 2018
    Assignee: St. Jude Medical Luxembourg Holdings SMI S.A.R.L. (“SJM LUX SMI”)
    Inventors: Eyad Kishawi, Mir A. Imran, Brian J. Mossop, Jeffery M. Kramer, Richard W. O'Connor
  • Publication number: 20170354822
    Abstract: Devices, systems and methods are provided for targeted treatment of a variety of conditions, particularly conditions that are associated with or influenced by the nervous system, such as pain. Targeted treatment of such conditions is provided with minimal deleterious side effects, such as undesired motor responses or undesired stimulation of unaffected body regions. This is achieved by directly neuromodulating a target anatomy associated with the condition while minimizing or excluding undesired neuromodulation of other anatomies.
    Type: Application
    Filed: August 28, 2017
    Publication date: December 14, 2017
    Inventors: Eyad KISHAWI, Mir A. IMRAN, Brian J. MOSSOP, Jeffery M. KRAMER, Richard W. O'CONNOR
  • Patent number: 9744360
    Abstract: Devices, systems and methods are provided for targeted treatment of a variety of conditions, particularly conditions that are associated with or influenced by the nervous system, such as pain. Targeted treatment of such conditions is provided with minimal deleterious side effects, such as undesired motor responses or undesired stimulation of unaffected body regions. This is achieved by directly neuromodulating a target anatomy associated with the condition while minimizing or excluding undesired neuromodulation of other anatomies.
    Type: Grant
    Filed: August 8, 2016
    Date of Patent: August 29, 2017
    Assignee: St. Jude Medical Luxembourg Holdings SMI S.A.R.L.
    Inventors: Eyad Kishawi, Mir A. Imran, Brian J. Mossop, Jeffery M. Kramer, Richard W. O'Connor
  • Publication number: 20160346547
    Abstract: Devices, systems and methods are provided for targeted treatment of a variety of conditions, particularly conditions that are associated with or influenced by the nervous system, such as pain. Targeted treatment of such conditions is provided with minimal deleterious side effects, such as undesired motor responses or undesired stimulation of unaffected body regions. This is achieved by directly neuromodulating a target anatomy associated with the condition while minimizing or excluding undesired neuromodulation of other anatomies.
    Type: Application
    Filed: August 8, 2016
    Publication date: December 1, 2016
    Inventors: Eyad KISHAWI, Mir A. IMRAN, Brian J. MOSSOP, Jeffery M. KRAMER, Richard W. O'CONNOR
  • Publication number: 20150258338
    Abstract: Devices, systems and methods are provided for targeted treatment of a variety of conditions, particularly conditions that are associated with or influenced by the nervous system, such as pain. Targeted treatment of such conditions is provided with minimal deleterious side effects, such as undesired motor responses or undesired stimulation of unaffected body regions. This is achieved by directly neuromodulating a target anatomy associated with the condition while minimizing or excluding undesired neuromodulation of other anatomies.
    Type: Application
    Filed: May 29, 2015
    Publication date: September 17, 2015
    Inventors: Eyad KISHAWI, Mir A. IMRAN, Brian J. MOSSOP, Jeffery M. KRAMER, Richard W. O'CONNER
  • Patent number: 9056197
    Abstract: Devices, systems and methods are provided for targeted treatment of a variety of conditions, particularly conditions that are associated with or influenced by the nervous system, such as pain. Targeted treatment of such conditions is provided with minimal deleterious side effects, such as undesired motor responses or undesired stimulation of unaffected body regions. This is achieved by directly neuromodulating a target anatomy associated with the condition while minimizing or excluding undesired neuromodulation of other anatomies.
    Type: Grant
    Filed: October 27, 2009
    Date of Patent: June 16, 2015
    Assignee: Spinal Modulation, Inc.
    Inventors: Eyad Kishawi, Mir A. Imran, Brian J. Mossop, Jeffery M. Kramer, Richard W. O'Connor
  • Patent number: 8914128
    Abstract: Methods, devices and systems are provided to efficiently identify, from among a plurality of possible neurostimulation parameter sets, one or more preferred neurostimulation parameter sets that treat a targeted pain of a patient. A plurality of different neurostimulation parameter sets are tested on the patient to thereby identify those tested neurostimulation parameter sets that treat the targeted pain. Each of the tested neurostimulation parameter sets defines an electrode configuration that differs from the other tested neurostimulation parameter sets.
    Type: Grant
    Filed: July 25, 2012
    Date of Patent: December 16, 2014
    Assignee: Spinal Modulation, Inc.
    Inventors: Mir A. Imran, Brian J. Mossop, Eyad Kishawi
  • Publication number: 20120290042
    Abstract: Methods, devices and systems are provided to efficiently identify, from among a plurality of possible neurostimulation parameter sets, one or more preferred neurostimulation parameter sets that treat a targeted pain of a patient. A plurality of different neurostimulation parameter sets are tested on the patient to thereby identify those tested neurostimulation parameter sets that treat the targeted pain. Each of the tested neurostimulation parameter sets defines an electrode configuration that differs from the other tested neurostimulation parameter sets.
    Type: Application
    Filed: July 25, 2012
    Publication date: November 15, 2012
    Applicant: SPINAL MODULATION, INC.
    Inventors: Mir A. Imran, Brian J. Mossop, Eyad Kishawi
  • Patent number: 8249701
    Abstract: Methods, devices and systems are provided to efficiently identify, from among a plurality of possible neurostimulation parameter sets, one or more preferred neurostimulation parameter sets that treat a targeted pain of a patient. Each neurostimulation parameter set defines electrode parameters and neurostimulation signal parameters. A plurality of different neurostimulation parameter sets are tested on the patient to thereby identify those tested neurostimulation parameter sets that treat the targeted pain. Each of the tested neurostimulation parameter sets defines an electrode configuration that differs from the other tested neurostimulation parameter sets. All of the tested neurostimulation parameter sets comprise a same value for a specific neurostimulation signal parameter (e.g., pulse width) that if reduced reduces power consumption.
    Type: Grant
    Filed: October 14, 2009
    Date of Patent: August 21, 2012
    Assignee: Spinal Modulation, Inc.
    Inventors: Mir A. Imran, Brian J. Mossop, Eyad Kishawi
  • Publication number: 20100137938
    Abstract: Devices, systems and methods are provided for targeted treatment of a variety of conditions, particularly conditions that are associated with or influenced by the nervous system, such as pain. Targeted treatment of such conditions is provided with minimal deleterious side effects, such as undesired motor responses or undesired stimulation of unaffected body regions. This is achieved by directly neuromodulating a target anatomy associated with the condition while minimizing or excluding undesired neuromodulation of other anatomies.
    Type: Application
    Filed: October 27, 2009
    Publication date: June 3, 2010
    Inventors: Eyad Kishawi, Mir A. Imran, Brian J. Mossop, Jeffery M. Kramer, Richard W. O'Connor
  • Publication number: 20100121408
    Abstract: Methods, devices and systems are provided to efficiently identify, from among a plurality of possible neurostimulation parameter sets, one or more preferred neurostimulation parameter sets that treat a targeted pain of a patient. Each neurostimulation parameter set defines electrode parameters and neurostimulation signal parameters. A plurality of different neurostimulation parameter sets are tested on the patient to thereby identify those tested neurostimulation parameter sets that treat the targeted pain. Each of the tested neurostimulation parameter sets defines an electrode configuration that differs from the other tested neurostimulation parameter sets. All of the tested neurostimulation parameter sets comprise a same value for a specific neurostimulation signal parameter (e.g., pulse width) that if reduced reduces power consumption.
    Type: Application
    Filed: October 14, 2009
    Publication date: May 13, 2010
    Applicant: SPINAL MODULATION, INC.
    Inventors: Mir A. Imran, Brian J. Mossop, Eyad Kishawi